Adaptimmune Therapeutics Plc ADR

Adaptimmune Therapeutics Plc ADR (ADAP) receives a Neutral rating from H.C. Wainwright
Samantha Gray
Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0 ...





